Get Premium to unlock powerful stock data
DHA:SQURPHARMA (Bangladesh)  
Square Pharmaceuticals Ltd logo

Square Pharmaceuticals Ltd

BDT 216.70 (-0.6%) Jun 30
P/E:
10.38
P/B:
1.93
Market Cap:
BDT 192.09B ($ 2.06B)
Enterprise V:
BDT 145.83B ($ 1.56B)
Volume:
1.15M
Avg Vol (2M):
358.95K
Volume:
1.15M
Market Cap BDT:
192.09B
Market Cap $:
2.06B
PE Ratio:
10.38
Avg Vol (2-Month):
358.95K
Enterprise Value BDT:
145.83B
Enterprise Value $:
1.56B
PB Ratio:
1.93
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
Square Pharmaceuticals Ltd is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. The company is also involved in the marketing of pesticide products. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. The company operates in Bangladesh and sells its products locally and internationally.
Name Current Vs Industry Vs History
Cash-To-Debt 26.35
Equity-to-Asset 0.94
Debt-to-Equity 0.02
Debt-to-EBITDA 0.08
Interest Coverage 595063.31
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 21.49
Distress
Grey
Safe
Beneish M-Score -2.18
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 55.4
9-Day RSI 53.11
14-Day RSI 50.28
6-1 Month Momentum % 0.7
12-1 Month Momentum % 0.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 17.91
Quick Ratio 15.77
Cash Ratio 14.56
Days Inventory 91.15
Days Sales Outstanding 11.13
Days Payable 9.21

Financials

DHA:SQURPHARMA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil BDT) 56,713.496
EPS (TTM) (BDT) 20.899
Beta 0
Volatility % 14.23
14-Day RSI 50.28
14-Day ATR (BDT) 2.394179
20-Day SMA (BDT) 216.34
12-1 Month Momentum % 0.14
52-Week Range (BDT) 207.7 - 251.9
Shares Outstanding (Mil) 886.45

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Square Pharmaceuticals Ltd Filings

Document Form Filing Date
No Filing Data